Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'k 115 free base'

Search results for: 'k 115 free base'

Items 1-10 of 55

Page
per page
  1. AM-095 free base
    A3167 AM-095 free base
    Target: LPA Receptors
    Summary: Potent LPA1 receptor antagonist
      insoluble in EtOH; ≥42 mg/mL
  2. BMS-345541(free base)
    B4655 BMS-345541(free base)
    Summary: IKK-1/IKK-2 inhibitor,potent and selective
      insoluble in H2O; ≥70 mg/mL
  3. TG100-115
    A2754 TG100-115
    Target: PI3K
    Summary: PI3Kγ/PI3Kδ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL
  4. MG-115
    A2612 MG-115
     1 Citation
    Target: Proteasome
    Summary: Potent reversible proteasome inhibitor
      ≥23.08 mg/mL
  5. K-252c
    A8344 K-252c
    Target: PKC|PKA
    Summary: Protein kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.55 mg/mL
  6. Ionomycin free acid
    B6947 Ionomycin free acid
    Target: Calcium ionophores
    Summary: calcium ionophore
      Soluble in ethanol or DMSO
  7. A23187, free acid
    B6646 A23187, free acid
    Summary: Ca2+ ionophore
      Soluble in DMSO
  8. CCT128930 HCl
    A8617 CCT128930 HCl
    Target: Akt
    Summary: AKT inhibitor
      insoluble in H2O; ≥17.1 mg/mL
  9. FK 866 hydrochloride
    A8631 FK 866 hydrochloride
    Target: NMPRTase
    Summary: NMPRTase inhibitor
      ≥18.95 mg/mL
  10. NVP-BSK805 2HCl
    A4148 NVP-BSK805 2HCl
    Target: JAK
    Summary: JAK2 inhibitor
      ≥30.8 mg/mL

Items 1-10 of 55

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 54item
  2. Natural Products 1 item
Specificity
  1. Selective 38item
Reversibility
  1. Reversible 2item
  2. Irreversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Proteasome 1 item
  3. Cathepsins 2item
  4. Histone Deacetylases (HDACs) 1 item
  5. Akt 1 item
  6. PI3K 3item
  7. MDM2 1 item
  8. AP-1 1 item
  9. MMP 1 item
  10. LPA Receptors 1 item
  11. PLK 1 item
  12. PDGFR 1 item
  13. FGFR 1 item
  14. Sir2-like Family Deacetylases (Sirtuins) 1 item
  15. Voltage-gated Sodium (NaV) Channels 2item
  16. Estrogen and Related Receptors 1 item
  17. EGFR 1 item
  18. JAK 1 item
  19. DNA-PK 1 item
  20. HSP90 1 item
  21. CFTR 1 item
  22. Cytochrome P450 (CYP450) 1 item
  23. ErbB 1 item
  24. c-MET 1 item
  25. PKC 3item
  26. Calpains 1 item
  27. 5-HT2 Receptors 2item
  28. Calcium ionophores 1 item
  29. PARP 1 item
  30. Sphingosine kinases (SphKs) 1 item
  31. NK1 Receptors 1 item
  32. PKA 1 item
  33. D2 Receptors 1 item
  34. Free Fatty Acid Receptors 2item
  35. C5a receptors 1 item
  36. Na /K ATPases 3item
  37. Na /K /Cl- Symporters (NKCCs) 2item
  38. GABAA Receptors 1 item
  39. 15-lipoxygenases 1 item
  40. Calcium-Activated Potassium (KCa) Channels 1 item
  41. Inward Rectifier Potassium (Kir) Channels 1 item
  42. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  43. Papains 1 item
  44. BACE 1 item
  45. DPP-4 1 item
  46. guanylyl cyclase 1 item
  47. FPTase 1 item
  48. NMPRTase 1 item
  49. p53 1 item
  50. insulin 1 item
  51. Ftase 1 item
  52. p21 1 item
  53. glutamate release 1 item
  54. HCV NS3-4A protease 1 item
Related Disease
  1. Breast Cancer 2item
  2. Cancer 20item
  3. Chronic Lymphocytic Leukemia 1 item
  4. Colon Cancer 1 item
  5. Colorectal Cancer 3item
  6. Diabetes 2item
  7. Glioblastoma 1 item
  8. Glioma 1 item
  9. Heart Failure 3item
  10. Hepatitis C 1 item
  11. Hepatocellular Carcinoma 2item
  12. Inflammatory Diseases 1 item
  13. Leukemia 1 item
  14. Melanoma 2item
  15. Multiple Myeloma 1 item
  16. Non-small Cell Lung Cancer 1 item
  17. Osteoporosis 2item
  18. Ovarian Cancer 1 item
  19. Prostate Cancer 4item
  20. Renal Cell Carcinoma 1 item
  21. Type 2 Diabetes 1 item